Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07643467

Fluorescent Probe for Assessment of Renal Elimination

Conditions: Augmented Renal Clearance, Critical Illness

Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: No
Phase: PHASE4
Enrollment: 200
Sponsor: Aaron Cook

Location: UKHealthCare/University of Kentucky Lexington Kentucky

Summary

Accurate measures of kidney function is important for precision dosing of many medications. The current methods of determining kidney function largely hinge on the use of equations that use common laboratory values such as serum creatinine \& static variables like age \& weight. These are helpful for trending over time, but often are inaccurate during times of medical illness. Other more accurate methods of measuring kidney function include urine collection, although this is not commonly used because of various reasons that make the collection inconvenient or unreliable. The new transdermal glomerular filtration (tGFR) device permits accurate, real-time evaluation of kidney function. This novel method has not been rigorously compared with urine collection \& other methods of determining kidney function in hospitalized patients. The goal of the study is to compare tGFR with other accepted methods of determining kidney function.

Eligibility Criteria

Inclusion Criteria: * 18-65 years old * critically ill or acutely ill hospitalized patients admitted to the intensive care unit * Stable/normal renal function Exclusion Criteria: * Prisoners * Pregnant women * Laboratory evidence of unstable kidney function (KDIGO AKI stage 1-3--This includes subjects with Scr \> 1.5x baseline)

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07643467). StuddyBuddy aggregates publicly available trial information.